Safety considerations in the pharmacological management of atrial fibrillation

International Journal of Cardiology
A John Camm

Abstract

The pharmacological management of atrial fibrillation (AF) requires careful consideration from a safety perspective. This article focuses primarily on maintenance therapy using antiarrhythmic drugs (AADs). The foremost safety issue for AADs is the propensity of class IA and III agents to cause torsade de pointes arrhythmias. Class IA drugs, particularly quinidine, can induce torsade de pointes at low or subtherapeutic doses, but higher doses are not necessarily associated with an increased incidence. 'Pure' class III drugs such as dofetilide induce torsade de pointes in a dose-related manner, but some class III agents with more complex actions such as amiodarone have a markedly lower potential to cause this arrhythmia. The risk of torsade de pointes precludes the use of class IA and 'pure' class III agents in patients with left ventricular hypertrophy and bradycardia. Class IC agents may cause sustained monomorphic ventricular tachycardias and are generally precluded in ischaemic and structural heart disease. Advanced heart failure patients may be treated with amiodarone or dofetilide, but most other AADs are unsuitable. The most important extracardiac toxicities occurring with AADs are those of amiodarone. Drug interactions ar...Continue Reading

References

Jul 1, 1991·Mayo Clinic Proceedings·J L Blackshear, H W Randle
Aug 1, 1990·Cardiovascular Drugs and Therapy·F DessertenneA Fabiato
Nov 1, 1990·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S Y Kim, N L Benowitz
Jan 2, 1990·The American Journal of Cardiology·L F SoykaR B Spangenberg
Jul 1, 1986·Journal of the American College of Cardiology·D M RodenR L Woosley
May 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H LewisH J Zimmerman
Apr 30, 1987·The American Journal of Cardiology·J T Bigger, D I Sahar
Jun 1, 1987·Journal of the American College of Cardiology·S C HammillD R Holmes
Jan 1, 1985·Drugs·V Legrand, P Collignon
Nov 1, 1993·European Heart Journal·R Lazzara
Jun 1, 1993·Circulation·D H Spodick
Aug 1, 1996·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·H T Dougall, J McLay
May 1, 2001·Cleveland Clinic Journal of Medicine·W I Saliba
Jun 9, 2001·Thyroid : Official Journal of the American Thyroid Association·F BogazziE Martino
Apr 30, 2002·American Journal of Epidemiology·Wendy A WattigneyJanet B Croft
Nov 14, 2002·American Journal of Ophthalmology·Paul J Lama
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Mar 12, 2003·Neuroepidemiology·Douglas A DulliRoss L Levine
Apr 12, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Weeranuj YamreudeewongDennis L Lower
May 15, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Bramah N Singh
Nov 5, 2003·Heart·Yee Guan Yap, A John Camm
Dec 21, 2004·Journal of the American College of Cardiology·Denis RoyUNKNOWN CRAFT Investigators
Nov 8, 2005·Progress in Cardiovascular Diseases·Robert N Goldstein, Bruce S Stambler
Mar 17, 2006·Drugs of Today·Karolina M Zareba
Apr 14, 2006·Expert Opinion on Drug Safety·Juan TamargoRicardo Caballero
Aug 1, 2006·Journal of the American College of Cardiology·Craig M PrattUNKNOWN Azimilide Trials Investigators
Oct 31, 2006·American Heart Journal·Steven N SinghUNKNOWN SCD-HeFT Investigators
Jul 31, 2007·British Journal of Clinical Pharmacology·Yvonne TschuppertJérôme Biollaz

❮ Previous
Next ❯

Citations

Apr 28, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Etienne AliotUNKNOWN World Heart Federation
May 16, 2009·Circulation Research·Sarah M SchumacherJeffrey R Martens
Dec 14, 2011·Circulation·Tomonori IgarashiJ Kevin Donahue
Apr 13, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Tsuyoshi ShigaNobuhisa Hagiwara
Jun 24, 2014·Revista Española De Cardiología·Maciej WójcikMalte Kuniss
Feb 3, 2016·Journal of Cardiac Surgery·Louay M Habbab, F Victor Chu
Jul 20, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chia-Ti TsaiJuey-Jen Hwang
Apr 7, 2010·The Journal of Thoracic and Cardiovascular Surgery·Robert W BoldermanJos G Maessen
Mar 6, 2010·International Journal of Cardiology·Robert W BoldermanJos G Maessen
Feb 17, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Sarah M Schumacher, Jeffrey R Martens
Dec 30, 2008·Cardiology Clinics·Noel G Boyle, Kalyanam Shivkumar
Jul 22, 2015·Nature Reviews. Cardiology·Gerrit Frommeyer, Lars Eckardt
Aug 10, 2015·The Journal of Thoracic and Cardiovascular Surgery·William WangXiao Dong Feng
Dec 17, 2008·Pharmacoepidemiology and Drug Safety
May 17, 2014·Pacing and Clinical Electrophysiology : PACE·Roy ChungMina K Chung
Mar 13, 2014·Pharmacoepidemiology and Drug Safety·Amarsinh M DesaiChristina M L Kelton
Oct 28, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Florian StraubeUNKNOWN FREEZE Cohort Investigators
Nov 21, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Shane F TsaiEmile G Daoud
Oct 4, 2014·Journal of the American College of Cardiology·Anil NigamUNKNOWN AFFORD Investigators
Jul 22, 2014·The Journal of Thoracic and Cardiovascular Surgery·Xiao Dong FengWilliam Wang
Jan 16, 2014·International Journal of Cardiology·Mónica TarapuésAlbert Figueras
Jan 12, 2013·International Journal of Cardiology·Jeroen M L HendriksHubertus J M Vrijhoef
Nov 24, 2011·International Journal of Cardiology·Christian Torp-PedersenGregory N Beatch
May 28, 2013·The American Journal of Cardiology·Genevieve BrumbergSandeep K Jain
Oct 14, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Malini GovindanA John Camm
Feb 14, 2018·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Gheorghe-Andrei DanUNKNOWN ESC Scientific Document Group
Sep 23, 2010·Circulation. Arrhythmia and Electrophysiology·Peter Leong-SitFrancis E Marchlinski
Aug 25, 2009·Journal of Cardiovascular Pharmacology·Robert W BoldermanJos G Maessen
Jun 4, 2010·Critical Pathways in Cardiology·Steven BarolettiJudy W M Cheng
Jul 30, 2015·Journal of Cardiovascular Pharmacology·J Kevin Donahue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

© 2021 Meta ULC. All rights reserved